Derek L. Stirewalt

19.0k total citations · 4 hit papers
84 papers, 14.2k citations indexed

About

Derek L. Stirewalt is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Derek L. Stirewalt has authored 84 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Hematology, 36 papers in Molecular Biology and 19 papers in Genetics. Recurrent topics in Derek L. Stirewalt's work include Acute Myeloid Leukemia Research (61 papers), Chronic Myeloid Leukemia Treatments (20 papers) and Acute Lymphoblastic Leukemia research (14 papers). Derek L. Stirewalt is often cited by papers focused on Acute Myeloid Leukemia Research (61 papers), Chronic Myeloid Leukemia Treatments (20 papers) and Acute Lymphoblastic Leukemia research (14 papers). Derek L. Stirewalt collaborates with scholars based in United States, South Africa and Germany. Derek L. Stirewalt's co-authors include Era L. Pogosova‐Agadjanyan, Muneesh Tewari, Jerald P. Radich, Patrick S. Mitchell, Evan M. Kroh, Jennifer Noteboom, Nicole Urban, Daniel Martin, April N. Allen and Peter S. Nelson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Nature reviews. Cancer.

In The Last Decade

Derek L. Stirewalt

80 papers receiving 14.0k citations

Hit Papers

Circulating microRNAs as stable blood-based markers for c... 2003 2026 2010 2018 2008 2011 2014 2003 2.0k 4.0k 6.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Derek L. Stirewalt United States 35 10.2k 8.5k 3.0k 1.1k 996 84 14.2k
Ramiro Garzon United States 42 10.9k 1.1× 8.9k 1.1× 2.0k 0.7× 774 0.7× 302 0.3× 142 13.5k
Adolfo A. Ferrando United States 65 15.8k 1.5× 8.6k 1.0× 4.4k 1.5× 1.3k 1.1× 4.7k 4.8× 164 23.7k
Sanford A. Stass United States 44 3.7k 0.4× 1.9k 0.2× 2.3k 0.8× 828 0.7× 1.4k 1.4× 143 7.5k
Chang‐Gong Liu United States 54 24.8k 2.4× 23.4k 2.8× 853 0.3× 996 0.9× 399 0.4× 76 30.3k
Era L. Pogosova‐Agadjanyan United States 17 9.0k 0.9× 8.1k 1.0× 643 0.2× 347 0.3× 211 0.2× 35 11.0k
Muller Fabbri United States 50 16.3k 1.6× 14.3k 1.7× 515 0.2× 758 0.7× 244 0.2× 101 19.7k
Julie Teruya‐Feldstein United States 77 13.1k 1.3× 5.5k 0.6× 2.1k 0.7× 2.1k 1.8× 361 0.4× 216 22.2k
Florea Lupu United States 60 4.3k 0.4× 2.7k 0.3× 2.8k 0.9× 911 0.8× 315 0.3× 182 12.3k
Arndt Borkhardt Germany 51 4.6k 0.5× 1.6k 0.2× 2.8k 0.9× 886 0.8× 2.5k 2.5× 342 10.2k
Andre C. Schuh Canada 35 4.9k 0.5× 1.0k 0.1× 2.5k 0.8× 947 0.8× 793 0.8× 181 7.8k

Countries citing papers authored by Derek L. Stirewalt

Since Specialization
Citations

This map shows the geographic impact of Derek L. Stirewalt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek L. Stirewalt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek L. Stirewalt more than expected).

Fields of papers citing papers by Derek L. Stirewalt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek L. Stirewalt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek L. Stirewalt. The network helps show where Derek L. Stirewalt may publish in the future.

Co-authorship network of co-authors of Derek L. Stirewalt

This figure shows the co-authorship network connecting the top 25 collaborators of Derek L. Stirewalt. A scholar is included among the top collaborators of Derek L. Stirewalt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek L. Stirewalt. Derek L. Stirewalt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biernacki, Melinda A., Kimberly A. Foster, Carrie Cummings, et al.. (2025). SF3B1K700E Neoantigen Is a CD8+ T-cell Target Shared across Human Myeloid Neoplasms. Cancer Immunology Research. 13(9). 1391–1404.
2.
Tregnago, Claudia, Rhonda E. Ries, Todd A. Alonzo, et al.. (2024). Influence of Nucleophosmin ( NPM1 ) Genotypes on Outcome of Patients With AML: An AIEOP-BFM and COG-SWOG Intergroup Collaboration. Journal of Clinical Oncology. 43(8). 972–984. 1 indexed citations
3.
Othus, Megan, Rhonda E. Ries, Jasmine Naru, et al.. (2024). Evaluation of ELN2022 Risk Stratification in NPM1 Mutated AML: A Study from the Fred Hutch and SWOG. Blood. 144(Supplement 1). 4309–4309.
4.
Biernacki, Melinda A., Kimberly A. Foster, Carrie Cummings, et al.. (2023). Discovery of U2AF1 neoantigens in myeloid neoplasms. Journal for ImmunoTherapy of Cancer. 11(12). e007490–e007490. 12 indexed citations
5.
Farrar, Jason E., Jenny L. Smith, Megan Othus, et al.. (2023). Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia. Journal of Clinical Oncology. 41(16). 2949–2962. 13 indexed citations
6.
Clough, Courtnee, Joseph Pangallo, Janine O. Ilagan, et al.. (2021). Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome. Blood. 139(13). 2038–2049. 45 indexed citations
7.
Pogosova‐Agadjanyan, Era L., Anna Moseley, Megan Othus, et al.. (2017). Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG Report. Biopreservation and Biobanking. 16(1). 42–52. 6 indexed citations
11.
Qu, Xiaoyu, Jerry Davison, Liping Du, et al.. (2015). Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia. Epigenetics. 10(6). 526–535. 20 indexed citations
12.
Dvinge, Heidi, Rhonda E. Ries, Janine O. Ilagan, et al.. (2014). Sample processing obscures cancer-specific alterations in leukemic transcriptomes. Proceedings of the National Academy of Sciences. 111(47). 16802–16807. 52 indexed citations
13.
Chevillet, John R., Qing Kang, Ingrid K. Ruf, et al.. (2014). Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proceedings of the National Academy of Sciences. 111(41). 14888–14893. 883 indexed citations breakdown →
14.
Stirewalt, Derek L., et al.. (2014). Copy-neutral loss of heterozygosity is prevalent and a late event in the pathogenesis of FLT3/ITD AML. Blood Cancer Journal. 4(5). e208–e208. 25 indexed citations
15.
Mitchell, Patrick S., Rachael K. Parkin, Evan M. Kroh, et al.. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences. 105(30). 10513–10518. 6512 indexed citations breakdown →
16.
Bar, Merav, Derek L. Stirewalt, Era L. Pogosova‐Agadjanyan, et al.. (2008). Gene Expression Patterns in Myelodyplasia Underline the Role of Apoptosis and Differentiation in Disease Initiation and Progression. PubMed. 1. 137–149. 12 indexed citations
17.
Stirewalt, Derek L., Soheil Meshinchi, Steven J. Kussick, et al.. (2004). Novel FLT3 point mutations within exon  14 found in patients with acute myeloid leukaemia. British Journal of Haematology. 124(4). 481–484. 43 indexed citations
18.
Stirewalt, Derek L. & Jerald P. Radich. (2003). The role of FLT3 in haematopoietic malignancies. Nature reviews. Cancer. 3(9). 650–665. 649 indexed citations breakdown →
19.
Stirewalt, Derek L., Katherine A. Guthrie, Lan Beppu, et al.. (2003). Predictors of relapse and overall survival in Philadelphia chromosome[ndash ]positive acute lymphoblastic leukemia after transplantation. Biology of Blood and Marrow Transplantation. 9(3). 206–212. 12 indexed citations
20.
Stirewalt, Derek L. & Jerald P. Radich. (2000). Tumor Suppressor Gene Aberrations in Acute Myelogenous Leukemia. Hematology. 5(1). 15–25. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026